Literature DB >> 12795648

Cyclooxygenase expression in splanchnic hyposensitivity to glypressin of bleeding portal hypertensive rats.

H-C Huang1, S-S Wang, Y-C Chen, F-Y Lee, F-Y Chang, H-C Lin, M-C Hou, C-C Chan, C-T Chen, S-L Wu, S-D Lee.   

Abstract

BACKGROUND: Prostacyclin mediates, at least partly, the splanchnic vascular hyporesponsiveness to glypressin in bleeding portal hypertensive rats. This study investigated the relative contribution of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) in the splanchnic hyposensitivity to glypressin in rats with portal hypertension induced by partial portal vein ligation (PVL).
METHODS: Fourteen days after the operation, the rats were divided into without- and with-bleeding groups. Three series of PVL rats were used to investigate (i). the haemodynamic effects of glypressin (0.07 mg x kg(-1) intravenously), (ii). COX-1/COX-2 mRNA expression over abdominal aorta and superior mesenteric artery and (iii). plasma levels of 6-keto-prostaglandin-F1alpha. In rats with a hypotensive haemorrhage, 4.5 mL of blood was withdrawn and 50% of the withdrawn blood was re-infused before blood and vessel sampling or the administration of glypressin.
RESULTS: Splanchnic hyposensitivity to glypressin was demonstrated in the haemorrhage-transfused PVL rats with enhanced COX-1 expression of superior mesenteric artery and increased plasma levels of 6-keto-prostaglandin-F1alpha. There were no differences in the COX-2 expression of superior mesenteric artery and COX-1 and COX-2 expressions of abdominal aorta between without- and with-bleeding groups.
CONCLUSION: In portal hypertensive rats with acute haemorrhage, COX-1 over-expression in the superior mesenteric artery plays a role in mediating the splanchnic hyposensitivity to glypressin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12795648     DOI: 10.1046/j.1365-2362.2003.01162.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  2 in total

1.  Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension.

Authors:  Francisco X Eizayaga; Omar Aguejouf; Vanessa Desplat; Philippe Belon; Christian Doutremepuich
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

2.  Adrenal dysfunction in portal hypertensive rats with acute hemorrhage.

Authors:  Fa-Yauh Lee; Sun-Sang Wang; Ming-Hung Tsai; Hui-Chun Huang; Han-Chieh Lin; Shou-Dong Lee
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.